X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Unichem Lab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES UNICHEM LAB JUBILANT LIFE SCIENCES/
UNICHEM LAB
 
P/E (TTM) x 26.2 33.1 79.2% View Chart
P/BV x 5.4 3.5 154.4% View Chart
Dividend Yield % 0.3 0.5 62.0%  

Financials

 JUBILANT LIFE SCIENCES   UNICHEM LAB
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
UNICHEM LAB
Mar-16
JUBILANT LIFE SCIENCES/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs187334 55.9%   
Low Rs65174 37.4%   
Sales per share (Unadj.) Rs364.3146.9 248.0%  
Earnings per share (Unadj.) Rs6.811.9 57.6%  
Cash flow per share (Unadj.) Rs24.516.2 151.3%  
Dividends per share (Unadj.) Rs3.002.00 150.0%  
Dividend yield (eoy) %2.40.8 302.5%  
Book value per share (Unadj.) Rs164.9105.1 156.9%  
Shares outstanding (eoy) m159.2890.84 175.3%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.31.7 20.0%   
Avg P/E ratio x18.421.4 86.1%  
P/CF ratio (eoy) x5.115.7 32.8%  
Price / Book Value ratio x0.82.4 31.6%  
Dividend payout %43.816.8 260.6%   
Avg Mkt Cap Rs m20,06123,073 86.9%   
No. of employees `0006.25.7 109.0%   
Total wages/salary Rs m11,0522,558 432.0%   
Avg. sales/employee Rs Th9,383.02,352.5 398.9%   
Avg. wages/employee Rs Th1,786.9450.9 396.3%   
Avg. net profit/employee Rs Th176.3190.4 92.6%   
INCOME DATA
Net Sales Rs m58,03413,346 434.9%  
Other income Rs m191192 99.3%   
Total revenues Rs m58,22413,538 430.1%   
Gross profit Rs m5,7861,639 353.0%  
Depreciation Rs m2,812390 720.9%   
Interest Rs m3,23729 11,240.3%   
Profit before tax Rs m-721,412 -5.1%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m0-4 0.0%   
Extraordinary Inc (Exp) Rs m2,145-35 -6,076.2%   
Tax Rs m696293 237.9%   
Profit after tax Rs m1,0901,080 100.9%  
Gross profit margin %10.012.3 81.2%  
Effective tax rate %-965.920.7 -4,659.8%   
Net profit margin %1.98.1 23.2%  
BALANCE SHEET DATA
Current assets Rs m29,2805,979 489.7%   
Current liabilities Rs m38,9122,432 1,600.0%   
Net working cap to sales %-16.626.6 -62.4%  
Current ratio x0.82.5 30.6%  
Inventory Days Days8463 133.8%  
Debtors Days Days5160 84.0%  
Net fixed assets Rs m55,7126,403 870.1%   
Share capital Rs m155182 85.0%   
"Free" reserves Rs m20,9689,293 225.6%   
Net worth Rs m26,2659,548 275.1%   
Long term debt Rs m17,169230 7,451.7%   
Total assets Rs m88,60612,843 689.9%  
Interest coverage x1.050.0 2.0%   
Debt to equity ratio x0.70 2,709.0%  
Sales to assets ratio x0.71.0 63.0%   
Return on assets %4.98.6 56.6%  
Return on equity %4.211.3 36.7%  
Return on capital %11.614.3 80.7%  
Exports to sales %37.829.2 129.3%   
Imports to sales %16.56.3 259.8%   
Exports (fob) Rs m21,9333,900 562.4%   
Imports (cif) Rs m9,567847 1,130.0%   
Fx inflow Rs m22,0044,356 505.1%   
Fx outflow Rs m11,7491,162 1,010.8%   
Net fx Rs m10,2553,194 321.1%   
CASH FLOW
From Operations Rs m8,0261,119 717.2%  
From Investments Rs m-1,744-853 204.4%  
From Financial Activity Rs m-4,447-334 1,330.8%  
Net Cashflow Rs m1,834-68 -2,685.9%  

Share Holding

Indian Promoters % 45.6 50.1 91.0%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 15.1 57.6%  
FIIs % 21.2 3.0 706.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 31.7 66.6%  
Shareholders   23,815 20,176 118.0%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   NATCO PHARMA  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare JUBILANT LIFE SCIENCES With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty at Record Close Yet Again; IT & Realty Stocks Rally(Closing)

Indian share markets extended rally in the final hour of the trade, hitting fresh record highs while the Bank nifty touched 27,000 level for the first time. At the closing bell.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 22, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS